1. Home
  2. ALVO vs HHH Comparison

ALVO vs HHH Comparison

Compare ALVO & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVO
  • HHH
  • Stock Information
  • Founded
  • ALVO 2013
  • HHH 2010
  • Country
  • ALVO Luxembourg
  • HHH United States
  • Employees
  • ALVO N/A
  • HHH N/A
  • Industry
  • ALVO Biotechnology: Pharmaceutical Preparations
  • HHH Real Estate Investment Trusts
  • Sector
  • ALVO Health Care
  • HHH Real Estate
  • Exchange
  • ALVO Nasdaq
  • HHH Nasdaq
  • Market Cap
  • ALVO 3.5B
  • HHH 4.2B
  • IPO Year
  • ALVO N/A
  • HHH N/A
  • Fundamental
  • Price
  • ALVO $12.39
  • HHH $83.88
  • Analyst Decision
  • ALVO Buy
  • HHH Strong Buy
  • Analyst Count
  • ALVO 1
  • HHH 2
  • Target Price
  • ALVO $18.00
  • HHH $82.00
  • AVG Volume (30 Days)
  • ALVO 81.0K
  • HHH 247.4K
  • Earning Date
  • ALVO 11-13-2024
  • HHH 11-04-2024
  • Dividend Yield
  • ALVO N/A
  • HHH N/A
  • EPS Growth
  • ALVO N/A
  • HHH N/A
  • EPS
  • ALVO N/A
  • HHH 1.52
  • Revenue
  • ALVO $393,919,000.00
  • HHH $1,195,412,000.00
  • Revenue This Year
  • ALVO $382.28
  • HHH $65.32
  • Revenue Next Year
  • ALVO $50.44
  • HHH N/A
  • P/E Ratio
  • ALVO N/A
  • HHH $55.13
  • Revenue Growth
  • ALVO 517.92
  • HHH 10.91
  • 52 Week Low
  • ALVO $9.00
  • HHH $56.24
  • 52 Week High
  • ALVO $18.00
  • HHH $84.96
  • Technical
  • Relative Strength Index (RSI)
  • ALVO 33.54
  • HHH 66.04
  • Support Level
  • ALVO $12.58
  • HHH $78.44
  • Resistance Level
  • ALVO $13.14
  • HHH $84.96
  • Average True Range (ATR)
  • ALVO 0.46
  • HHH 1.90
  • MACD
  • ALVO -0.16
  • HHH 0.03
  • Stochastic Oscillator
  • ALVO 2.48
  • HHH 85.16

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

About HHH Howard Hughes Holdings Inc.

Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments, and Seaport.

Share on Social Networks: